235
Views
29
CrossRef citations to date
0
Altmetric
Original

In vitro investigation of immunomodulatory effects caused by engineered inorganic nanoparticles – the impact of experimental design and cell choice

, , , &
Pages 46-59 | Received 06 Aug 2008, Published online: 10 Jul 2009
 

Abstract

This study describes immunomodulatory effects of small inorganic nanoparticles and the impact of experimental design therein. Gold, cobalt oxide and iron oxide nanoparticles were synthesized in solution under conditions that ensured monodispersed and stable particles in solvents and when diluted in cell culture medium. Particles and solvents were tested for their cytotoxic and cytokine regulatory effects on immortalized and primary human lung epithelial cells in the absence and presence of the pro-inflammatory cytokine TNF-α. The particle-suspensions and solvents were not cytotoxic, but a significant effect on cytokine induction due to the chemical solvents was observed, although these are routinely used in nanoparticles synthesis. Significant immunomodulatory effects of some particle types on the immortalized epithelial cells were observed, these effects were more pronounced in primary epithelial cells. In conclusion, the solvent used to prepare the nanoparticles and the choice of cell type can affect the outcome of nanotoxicological studies.

Acknowledgements

The authors thank Maria Schmittner for her technical assistance. Moreover, we would like to thank Dr Klaus Wittmaack for critical reading of the manuscript. Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.